CPA
Cowen Prime Advisors’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $3.71M | Sell |
51,820
-1,700
| -3% | -$122K | 1.28% | 17 |
|
|
2023
Q1 | $3.92M | Buy |
53,520
+1,500
| +3% | +$110K | 1.57% | 17 |
|
|
2022
Q4 | $3.53M | Hold |
52,020
| – | – | 1.45% | 17 |
|
|
2022
Q3 | $2.85M | Buy |
52,020
+725
| +1% | +$39.8K | 1.64% | 15 |
|
|
2022
Q2 | $3.39M | Sell |
51,295
-125
| -0.2% | -$8.26K | 1.93% | 11 |
|
|
2022
Q1 | $3.41M | Hold |
51,420
| – | – | 1.44% | 16 |
|
|
2021
Q4 | $3M | Sell |
51,420
-3,000
| -6% | -$175K | 1.02% | 27 |
|
|
2021
Q3 | $3.27M | Buy |
54,420
+800
| +1% | +$48K | 1.22% | 21 |
|
|
2021
Q2 | $3.21M | Buy |
53,620
+100
| +0.2% | +$5.99K | 1.17% | 22 |
|
|
2021
Q1 | $2.66M | Buy |
53,520
+250
| +0.5% | +$12.4K | 1.01% | 26 |
|
|
2020
Q4 | $2.66M | Buy |
53,270
+2,550
| +5% | +$127K | 1.18% | 17 |
|
|
2020
Q3 | $2.78M | Sell |
50,720
-575
| -1% | -$31.5K | 1.35% | 20 |
|
|
2020
Q2 | $3.39M | Buy |
51,295
+375
| +0.7% | +$24.8K | 1.93% | 11 |
|
|
2020
Q1 | $2.27M | Buy |
+50,920
| New | +$2.27M | 1.39% | 17 |
|
|
2019
Q1 | – | Sell |
-73,040
| Closed | -$2.77M | – | 179 |
|
|
2018
Q4 | $2.77M | Buy |
73,040
+1,750
| +2% | +$66.5K | 1.67% | 16 |
|
|
2018
Q3 | $2.82M | Sell |
71,290
-7,400
| -9% | -$293K | 1.31% | 24 |
|
|
2018
Q2 | $2.76M | Buy |
78,690
+11,250
| +17% | +$395K | 1.36% | 22 |
|
|
2018
Q1 | $2.36M | Buy |
67,440
+13,920
| +26% | +$487K | 1.31% | 25 |
|
|
2017
Q4 | $1.86M | Buy |
+53,520
| New | +$1.86M | 0.9% | 35 |
|